ACCESSION: MSBNK-SMB_Measured-HSA014P0318000
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; NEGATIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 29
COMMENT: RAW_SPEC {'EL02-neg_1840': {'bp': 147441.0, 'sum': 376090.0}, 'EL02-neg_1808': {'bp': 120173.0, 'sum': 339090.0}, 'EL06-neg_1799': {'bp': 112091.0, 'sum': 294811.0}, 'EL06-neg_1833': {'bp': 110866.0, 'sum': 323632.0}, 'EL15-neg_1811': {'bp': 109723.0, 'sum': 296264.0}, 'EL01-neg_1804': {'bp': 101238.0, 'sum': 271164.0}, 'EL09-neg_1806': {'bp': 100142.0, 'sum': 262944.0}, 'EL19-neg_1811': {'bp': 98222.0, 'sum': 279833.0}, 'EL13-neg_1803': {'bp': 97865.0, 'sum': 278100.0}, 'EL17-neg_1799': {'bp': 97438.0, 'sum': 277218.0}, 'EL04-neg_1804': {'bp': 90707.0, 'sum': 273871.0}, 'EL03-neg_1805': {'bp': 85832.0, 'sum': 271926.0}, 'EL05-neg_1803': {'bp': 82864.0, 'sum': 244009.0}, 'EL18-neg_1798': {'bp': 82773.0, 'sum': 229400.0}, 'EL08-neg_1803': {'bp': 80011.0, 'sum': 259524.0}, 'EL12-neg_1806': {'bp': 78719.0, 'sum': 243118.0}, 'EL03-neg_1839': {'bp': 71951.0, 'sum': 249478.0}, 'EL16-neg_1803': {'bp': 70216.0, 'sum': 227280.0}, 'EL11-neg_1811': {'bp': 70135.0, 'sum': 232633.0}, 'EL20-neg_1816': {'bp': 69217.0, 'sum': 212408.0}, 'EL05-neg_1835': {'bp': 69168.0, 'sum': 216542.0}, 'EL21-neg_1802': {'bp': 69146.0, 'sum': 223892.0}, 'EL10-neg_1824': {'bp': 67762.0, 'sum': 200578.0}, 'EL14-neg_1812': {'bp': 63611.0, 'sum': 216172.0}, 'EL24-neg_1806': {'bp': 62441.0, 'sum': 199554.0}, 'EL23-neg_1806': {'bp': 57425.0, 'sum': 188368.0}, 'EL22-neg_1824': {'bp': 56186.0, 'sum': 185294.0}, 'EL07-neg_1818': {'bp': 52940.0, 'sum': 181797.0}, 'EL23-neg_1840': {'bp': 46883.0, 'sum': 179039.0}}
COMMENT: RETENTION_TIME_STDEV 0.022
COMMENT: PRECURSOR_M/Z_RAW 318.076467
COMMENT: PRECURSOR_M/Z_STDEV 0.000151
COMMENT: PRECURSOR_IN_MS1 mz 318.076411; int 22.589; delta(ppm) 0.823867
COMMENT: PROPOSED_CHARGE_STATE -1; mz 319.079691; int 2.845; cor 0.709
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M-H; M+Na-2H; mz 340.058486; int 1.737; cor 0.802
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 4.366; C11H19N3O4P2; [M-H]1; delta(ppm) -4.365626
COMMENT: PROPOSED_MF SevenGoldenRules 2.429; C19H13NO4; [M-H]1; delta(ppm) -2.428830
COMMENT: PROPOSED_MF SevenGoldenRules 0.812; C13H14N5O3P; [M-H]1; delta(ppm) 0.811699
COMMENT: PROPOSED_MF MS-FINDER 3.424; C11H17N3O6S; [M-H]-; delta(ppm) -0.386274
COMMENT: PROPOSED_MF MS-FINDER 2.953; C19H13NO4; [M-H]-; delta(ppm) -2.434875
COMMENT: PROPOSED_MF MS-FINDER 2.640; C13H14N5O3P; [M-H]-; delta(ppm) 0.814529
COMMENT: PROPOSED_MF MS-FINDER 2.551; C5H18N7O5PS; [M-H]-; delta(ppm) 2.863144
COMMENT: PROPOSED_MF MS-FINDER 2.229; C11H19N3O4P2; [M-H]-; delta(ppm) -4.378439
COMMENT: PROPOSED_MF MS-FINDER 2.152; C13H22NO2PS2; [M-H]-; delta(ppm) 2.287125
COMMENT: PROPOSED_MF MS-FINDER 1.975; C12H18NO7P; [M-H]-; delta(ppm) 5.019248
COMMENT: PROPOSED_MF MS-FINDER 1.948; C12H13N7O2S; [M-H]-; delta(ppm) -4.590947
COMMENT: PROPOSED_MF MS-FINDER 1.866; C12H21N3OS3; [M-H]-; delta(ppm) -3.118367
COMMENT: PROPOSED_MF MS-FINDER 1.835; C8H9N13S; [M-H]-; delta(ppm) 3.851444
COMMENT: PROPOSED_MF SIRIUS5_Sirius 17.336; C11H17N3O6S; [M-H]-; delta(ppm) -0.386274
COMMENT: PROPOSED_MF SIRIUS5_Sirius 12.210; C19H13NO4; [M-H]-; delta(ppm) -2.434875
COMMENT: PROPOSED_MF SIRIUS5_Sirius 12.203; C14H14ClN5O2; [M-H]-; delta(ppm) -70159.544671
COMMENT: PROPOSED_MF SIRIUS5_Sirius -1.400; C15H17N3OS2; [M-H]-; delta(ppm) 7.480162
COMMENT: PROPOSED_MF SIRIUS5_Sirius -2.378; C20H14FNS; [M-H]-; delta(ppm) 1.839115
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C11H17N3O6S; [M-H]-; delta(ppm) -0.386274
COMMENT: PROPOSED_MF SIRIUS6_Sirius 26.040; C11H17N3O6S; [M-H]-; delta(ppm) -0.386274
COMMENT: PROPOSED_MF SIRIUS6_Sirius 18.177; C14H14ClN5O2; [M-H]-; delta(ppm) -70159.544671
COMMENT: PROPOSED_MF SIRIUS6_Sirius 17.784; C19H13NO4; [M-H]-; delta(ppm) -2.434875
COMMENT: PROPOSED_MF SIRIUS6_Sirius 16.284; C12H19ClN3O3P; [M-H]-; delta(ppm) -70164.034523
COMMENT: PROPOSED_MF SIRIUS6_Sirius 15.819; C17H11N4O3; [M-H]-; delta(ppm) 1.786321
COMMENT: PROPOSED_MF SIRIUS6_Sirius 15.703; C14H15N4O3S; [M-H]-; delta(ppm) -8.812089
COMMENT: PROPOSED_MF SIRIUS6_Sirius 15.624; C12H13N7O2S; [M-H]-; delta(ppm) -4.590947
COMMENT: PROPOSED_MF SIRIUS6_Sirius 15.354; C9H15N6O5S; [M-H]-; delta(ppm) 3.834939
COMMENT: PROPOSED_MF SIRIUS6_Sirius 15.229; C10H17N3O7Si; [M-H]-; delta(ppm) -167383.807796
COMMENT: PROPOSED_MF SIRIUS6_Sirius 15.056; C13H18ClNO6; [M-H]-; delta(ppm) -70155.909265
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C11H17N3O6S; [M-H]-; delta(ppm) -0.386274
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.545; LUICKNVDPFXVDI-UHFFFAOYSA-N; [M-H]-; O=C1NC(=O)C(=C2OCOC2=C1C1=CC=CC=C1)C1=CC=CC=C1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.506; RCDIUAFMNCXJRV-UHFFFAOYSA-N; [M-H]-; CCOC(=O)C1=C2C=CC=CN2C2=C1C(=O)C1=CC=CC=C1C2=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.497; ZCMNYBNYFRAPIS-UHFFFAOYSA-N; [M-H]-; COC1=C(O)C=C2C(C=NC3=C2C=CC2=CC4=C(OCO4)C=C32)=C1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.489; FTZMLNMSFGGSHW-UHFFFAOYSA-N; [M-H]-; O=C1C=CC2=CNC3=C(C=CC=4C=C5OCOC5=CC43)C2=C1OC
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.482; HAGHYGAMEAVUTF-UHFFFAOYSA-N; [M-H]-; O=C1OC=2C=C3OCOC3=CC2C(C=4C=CC5=NC=CC=C5C4)C1
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.968; RJUNHHFZFRMZQQ-FDDDBJFASA-N; [M-H]-; 5-methoxyaminomethyl-2-thiouridine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.656; GJJFWGQGJJGJEO-UHFFFAOYSA-N; [M-H]-; Decarine;Rutaceline
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.604; FRSOYBXQJMIDQW-UHFFFAOYSA-N; [M-H]-; Isodecarine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.604; FYJSYMQIPQSCAB-UHFFFAOYSA-N; [M-H]-; Zanthoxyline
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.592; LUICKNVDPFXVDI-UHFFFAOYSA-N; [M-H]-; UNPD145473
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.551; ZCMNYBNYFRAPIS-UHFFFAOYSA-N; [M-H]-; UNPD138262
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.550; KBKYPWIHYIERCX-UHFFFAOYSA-N; [M-H]-; 3-[5-(4-nitrophenyl)furan-2-yl]-1-phenylprop-2-en-1-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.550; QKPZPUDBHPOCTB-UHFFFAOYSA-N; [M-H]-; 3-[5-(3-nitrophenyl)furan-2-yl]-1-phenylprop-2-en-1-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.502; RCDIUAFMNCXJRV-UHFFFAOYSA-N; [M-H]-; 6,11-dioxo-12-naphtho[2,3-b]indolizinecarboxylic acid ethyl ester
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.502; UFJGFNHRMPMALC-UHFFFAOYSA-N; [M-H]-; ethyl 8,15-dioxo-14-azatetracyclo[7.7.1.0?,?.0??,??]heptadeca-1(16),2,4,6,9,11,13(17)-heptaene-16-carboxylate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.502; UPXQMMGMYZLGGL-UHFFFAOYSA-N; [M-H]-; 3-(1-acetyl-1H-indol-3-yl)-4-hydroxy-2H-chromen-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.494; BQXIZERVPFANMV-UHFFFAOYSA-N; [M-H]-; 6-hydroxy-2-[(6-methoxyquinolin-2-yl)methylidene]-2,3-dihydro-1-benzofuran-3-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.494; NZRLQRITLBCBDK-UHFFFAOYSA-N; [M-H]-; 6-hydroxy-2-[(8-methoxyquinolin-2-yl)methylidene]-2,3-dihydro-1-benzofuran-3-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.487; GHZMAPGQZOCDCA-UHFFFAOYSA-N; [M-H]-; N-(2-oxo-2H-chromen-6-yl)-2H-chromene-3-carboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.483; GTJORMGEUQRCAP-UHFFFAOYSA-N; [M-H]-; 3-(1-acetyl-1H-indol-3-yl)-3,4-dihydro-2H-1-benzopyran-2,4-dione
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.482; NUKXOXYUQLLJRG-UHFFFAOYSA-N; [M-H]-; 13-(quinolin-4-yl)-4,6,10-trioxatricyclo[7.4.0.0?,?]trideca-1(9),2,7-trien-11-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.481; HAGHYGAMEAVUTF-UHFFFAOYSA-N; [M-H]-; 13-(quinolin-6-yl)-4,6,10-trioxatricyclo[7.4.0.0?,?]trideca-1(9),2,7-trien-11-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.458; FTZMLNMSFGGSHW-UHFFFAOYSA-N; [M-H]-; 15-methoxy-5,7-dioxa-21-azapentacyclo[11.8.0.0?,??.0?,?.0??,??]henicosa-1,3,8,10,12,14,17,19-octaen-16-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; GHZMAPGQZOCDCA-UHFFFAOYSA-N; [M-H]-; N-(2-oxo-2H-chromen-6-yl)-2H-chromene-3-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.955; LUICKNVDPFXVDI-UHFFFAOYSA-N; [M-H]-; UNPD145473
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.949; KBKYPWIHYIERCX-UHFFFAOYSA-N; [M-H]-; 3-[5-(4-nitrophenyl)furan-2-yl]-1-phenylprop-2-en-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.949; QKPZPUDBHPOCTB-UHFFFAOYSA-N; [M-H]-; 3-[5-(3-nitrophenyl)furan-2-yl]-1-phenylprop-2-en-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.929; UFJGFNHRMPMALC-UHFFFAOYSA-N; [M-H]-; ethyl 8,15-dioxo-14-azatetracyclo[7.7.1.0?,?.0??,??]heptadeca-1(16),2,4,6,9,11,13(17)-heptaene-16-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.891; GTJORMGEUQRCAP-UHFFFAOYSA-N; [M-H]-; 3-(1-acetyl-1H-indol-3-yl)-3,4-dihydro-2H-1-benzopyran-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.888; UPXQMMGMYZLGGL-UHFFFAOYSA-N; [M-H]-; 3-(1-acetyl-1H-indol-3-yl)-4-hydroxy-2H-chromen-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.500; RCDIUAFMNCXJRV-UHFFFAOYSA-N; [M-H]-; 6,11-dioxo-12-naphtho[2,3-b]indolizinecarboxylic acid ethyl ester
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.424; BQXIZERVPFANMV-UHFFFAOYSA-N; [M-H]-; 6-hydroxy-2-[(6-methoxyquinolin-2-yl)methylidene]-2,3-dihydro-1-benzofuran-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.424; NZRLQRITLBCBDK-UHFFFAOYSA-N; [M-H]-; 6-hydroxy-2-[(8-methoxyquinolin-2-yl)methylidene]-2,3-dihydro-1-benzofuran-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.361; NUKXOXYUQLLJRG-UHFFFAOYSA-N; [M-H]-; 13-(quinolin-4-yl)-4,6,10-trioxatricyclo[7.4.0.0?,?]trideca-1(9),2,7-trien-11-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.360; HAGHYGAMEAVUTF-UHFFFAOYSA-N; [M-H]-; 13-(quinolin-6-yl)-4,6,10-trioxatricyclo[7.4.0.0?,?]trideca-1(9),2,7-trien-11-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.209; FRSOYBXQJMIDQW-UHFFFAOYSA-N; [M-H]-; Isodecarine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.209; FYJSYMQIPQSCAB-UHFFFAOYSA-N; [M-H]-; Zanthoxyline
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.209; GJJFWGQGJJGJEO-UHFFFAOYSA-N; [M-H]-; Decarine;Rutaceline
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.209; ZCMNYBNYFRAPIS-UHFFFAOYSA-N; [M-H]-; UNPD138262
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.164; FTZMLNMSFGGSHW-UHFFFAOYSA-N; [M-H]-; 15-methoxy-5,7-dioxa-21-azapentacyclo[11.8.0.0?,??.0?,?.0??,??]henicosa-1,3,8,10,12,14,17,19-octaen-16-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -517.656; RJUNHHFZFRMZQQ; [M-H]-; 5-methoxyaminomethyl-2-thiouridine
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.035; RJUNHHFZFRMZQQ; [M-H]-; 5-methoxyaminomethyl-2-thiouridine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -141.632; OUXAHOANTCKXTR; [M-H]-; (2S)-2-amino-5-[[1-(carboxymethylcarbamoyl)-2-sulfanylcyclopropyl]amino]-5-oxopentanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -146.132; ZCLYJPCIFKYNSX; [M-H]-; 6-[(4-Amino-4-carboxybutanoyl)amino]-5-oxo-1,4-thiazepane-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -199.704; JXKWFCVATGHWNP; [M-H]-; 2-Amino-5-[[1-(carboxymethylamino)-1-oxo-3-sulfanylpropan-2-yl]amino]-3-methylidene-5-oxopentanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -231.595; FSWPUGRTQHLTSA; [M-H]-; (2S)-1-[[(2R)-2-Amino-3-(carboxymethylamino)-3-oxopropyl]thiomethyl]-5-oxopyrrolidine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -238.204; HTEYNDCKYNWPGE; [M-H]-; N-Acetylglycyl-S-acetyl-L-cysteinylglycine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -251.671; JLQJUZAHSRXLEA; [M-H]-; 2-[[2-[(4-Amino-5,6-dioxohexanoyl)amino]-3-sulfanylpropanoyl]amino]acetic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -300.086; OOFVUIDXPPAXMA; [M-H]-; (2S)-5-ethoxy-2-[(1-methylpyrazol-4-yl)sulfonylamino]-5-oxopentanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -308.991; FPRBHTBHGIPWTE; [M-H]-; (2S)-5-ethoxy-2-[(2-methylpyrazol-3-yl)sulfonylamino]-5-oxopentanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -311.655; MJRKNWHBDWFNSF; [M-H]-; (2S)-2-[(3,5-dimethyl-1H-pyrazol-4-yl)sulfonylamino]-5-methoxy-5-oxopentanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -325.365; OYKRJSUNEOBYEW; [M-H]-; (2S)-2-[(1,3,5-trimethylpyrazol-4-yl)sulfonylamino]pentanedioic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.246; OUXAHOANTCKXTR; [M-H]-; (2S)-2-amino-5-[[1-(carboxymethylcarbamoyl)-2-sulfanylcyclopropyl]amino]-5-oxopentanoic acid
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C11H16N3O6S1; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE NEGATIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 µm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 3.094
MS$FOCUSED_ION: PRECURSOR_M/Z 318.076407
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-004i-1901000000-2284c833744790165b44
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  58.0284275 54.9134 58.028403 1.2063 11.53 0.7043 26 ?
  74.0233178 82.2441 74.023302 1.1213 14.56 0.7805 28 ?
  78.9576461 39.9255 78.957634 1.3678 13.90 0.1214 24 ?
  99.0549652 86.5964 99.054977 1.1408 13.40 0.7894 29 ?
  99.9243724 125.3829 99.924385 1.0908 36.75 -0.3730 28 ?
  128.0340129 999.0000 128.034077 0.5155 0.00 0.8993 29 ?
  129.0375476 46.7542 129.037613 1.3562 12.64 0.7403 23 ?
  143.0449911 231.0765 143.045091 0.8109 30.41 0.9300 27 f{C5H7N2O3}/-8.56ppm,p-C6H9N1O3S1
  174.0220153 158.0239 174.022208 1.0976 20.15 0.7794 26 f{C6H8N1O3S1}/-5.88ppm,p-C5H8N2O3
  177.0330495 145.8851 177.033252 1.1919 15.73 0.8464 22 f{C5H9N2O3S1}/-5.01ppm,p-C6H7N1O3
  199.8509593 223.9729 199.850427 0.7756 67.76 0.0226 29 ?
  200.8514523 32.1640 200.850929 1.2596 11.72 -0.3495 22 ?
  318.0764357 265.3310 318.076754 1.1004 29.36 1.0000 27 f{C11H16N3O6S1}/-0.30ppm,p
PK$NUM_PEAK: 13
PK$PEAK: m/z int. rel.int.
  58.028428 54.91 54
  74.023318 82.24 82
  78.957646 39.93 39
  99.054965 86.60 86
  99.924372 125.38 125
  128.034013 999.00 999
  129.037548 46.75 46
  143.044991 231.08 231
  174.022015 158.02 158
  177.033050 145.89 145
  199.850959 223.97 223
  200.851452 32.16 32
  318.076436 265.33 265
//
